Osaic Holdings
ANVS icon

Osaic Holdings’s Annovis Bio ANVS Stock Holding History

Osaic Holdings’s Portfolio ANVS Stock Details ANVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$391 Buy
210
+200
+2,000% +$389 ﹤0.01% 7697
2026
Q1 		$22 Sell
10
-200
-95% -$548 ﹤0.01% 7714
2025
Q4 		$727 Hold
210
– – ﹤0.01% 7357
2025
Q3 		$429 Sell
210
-467
-69% -$1.17K ﹤0.01% 7566
2025
Q2 		$1.47K Buy
677
+75
+12% +$148 ﹤0.01% 7044
2025
Q1 		$903 Buy
602
+100
+20% +$306 ﹤0.01% 6858
2024
Q4 		$2.52K Sell
502
-698
-58% -$5.05K ﹤0.01% 6511
2024
Q3 		$9.67K Sell
1,200
-75
-6% -$703 ﹤0.01% 5836
2024
Q2 		$7.34K Buy
1,275
+75
+6% +$608 ﹤0.01% 5972
2024
Q1 		$14.3K Hold
1,200
– – ﹤0.01% 5547
2023
Q4 		$22.4K Hold
1,200
– – ﹤0.01% 5438
2023
Q3 		$11.4K Sell
1,200
-956
-44% -$11.8K ﹤0.01% 5852
2023
Q2 		$30.1K Hold
2,156
– – ﹤0.01% 5286
2023
Q1 		$30.5K Sell
2,156
-1,210
-36% -$19.5K ﹤0.01% 5308
2022
Q4 		$45K Buy
3,366
+86
+3% +$1.07K ﹤0.01% 5012
2022
Q3 		$45K Buy
3,280
+1,210
+58% +$15.9K ﹤0.01% 4988
2022
Q2 		$25K Sell
2,070
-800
-28% -$8.75K ﹤0.01% 5453
2022
Q1 		$38K Sell
2,870
-5,724
-67% -$82.7K ﹤0.01% 5278
2021
Q4 		$152K Sell
8,594
-2,408
-22% -$62.1K ﹤0.01% 4213
2021
Q3 		$349K Buy
11,002
+9,260
+532% +$532K ﹤0.01% 3393
2021
Q2 		$149K Sell
1,742
-2,458
-59% -$114K ﹤0.01% 4130
2021
Q1 		$117K Sell
4,200
-3,196
-43% -$68.4K ﹤0.01% 4215
2020
Q4 		$56K Sell
7,396
-438
-6% -$2.37K ﹤0.01% 4475
2020
Q3 		$38K Buy
7,834
+7,409
+1,743% +$39.7K ﹤0.01% 4499
2020
Q2 		$2K Hold
425
– – ﹤0.01% 5757
2020
Q1 		$1K Buy
+425
New +$2.09K ﹤0.01% 5792

Other funds holding ANVS

EAM
Empery Asset Management New York $86.5M AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $71.9B AUM 42.37% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Osaic Holdings's ANVS Position: Q2 2026 in Review

Osaic Holdings increased its Annovis Bio (ANVS) stake by 2,000% in Q2 2026, buying an estimated $389 and bringing the position to 210 shares worth $391. The position accounts for ﹤0.01% of the portfolio, ranked #7697.

Osaic Holdings first reported a position in ANVS in Q1 2020 and has held it in 26 quarters since. The position peaked at $349K in Q3 2021. 61 funds tracked by Wall St. Rank hold ANVS as of Q2 2026.

  • Osaic Holdings held 210 shares of Annovis Bio worth $391 as of Q2 2026.
  • Osaic Holdings bought 200 Annovis Bio shares in Q2 2026, an estimated $389.
  • Annovis Bio made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #7697 holding.
  • Osaic Holdings first reported a position in Annovis Bio in Q1 2020 and has held it in 26 quarters since.
  • Osaic Holdings's Annovis Bio position peaked at $349K in Q3 2021.
  • 61 funds tracked by Wall St. Rank held Annovis Bio as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.